Egyptian health officials recall six drugs
The Egyptian Drug Authority issued urgent directives to withdraw and seize all quantities of six pharmaceutical products containing Chlorodiazepoxide in their formulation due to concerns related to the use of this substance. The process included the following medications: CLOXIDE, DIBREX, COLOVERIN A, LIBRAX, CLIDIASPASM, and EPIRAX. Pharmacies are required to return all remaining amounts to the manufacturing companies no later than August 20, 2026. This measure is part of the Authority’s efforts to monitor the pharmaceutical market and protect public health from potential risks associated with the use of these products.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)